362 related articles for article (PubMed ID: 18990939)
41. Herbal Drugs and Natural Products in the light of Nanotechnology and Nanomedicine for Developing Drug Formulations.
Ahmed HM; Nabavi S; Behzad S
Mini Rev Med Chem; 2021; 21(3):302-313. PubMed ID: 32938347
[TBL] [Abstract][Full Text] [Related]
42. Syntheses and applications of Mn-doped II-VI semiconductor nanocrystals.
Yang H; Santra S; Holloway PH
J Nanosci Nanotechnol; 2005 Sep; 5(9):1364-75. PubMed ID: 16193951
[TBL] [Abstract][Full Text] [Related]
43. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
Figuerola A; Di Corato R; Manna L; Pellegrino T
Pharmacol Res; 2010 Aug; 62(2):126-43. PubMed ID: 20044004
[TBL] [Abstract][Full Text] [Related]
44. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
45. Electrospinning: methods and development of biodegradable nanofibres for drug release.
Ashammakhi N; Wimpenny I; Nikkola L; Yang Y
J Biomed Nanotechnol; 2009 Feb; 5(1):1-19. PubMed ID: 20055102
[TBL] [Abstract][Full Text] [Related]
46. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
Müller RH; Jacobs C; Kayser O
Adv Drug Deliv Rev; 2001 Mar; 47(1):3-19. PubMed ID: 11251242
[TBL] [Abstract][Full Text] [Related]
47. Micro- and nano-motors: the new generation of drug carriers.
Medina-Sánchez M; Xu H; Schmidt OG
Ther Deliv; 2018 Mar; 9(4):303-316. PubMed ID: 29540126
[TBL] [Abstract][Full Text] [Related]
48. Size-dependent sedimentation properties of nanocrystals.
Jamison JA; Krueger KM; Yavuz CT; Mayo JT; LeCrone D; Redden JJ; Colvin VL
ACS Nano; 2008 Feb; 2(2):311-9. PubMed ID: 19206632
[TBL] [Abstract][Full Text] [Related]
49. Drug loading of nanoporous TiO2 films.
Ayon AA; Cantu M; Chava K; Agrawal CM; Feldman MD; Johnson D; Patel D; Marton D; Shi E
Biomed Mater; 2006 Dec; 1(4):L11-5. PubMed ID: 18458401
[TBL] [Abstract][Full Text] [Related]
50. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
[TBL] [Abstract][Full Text] [Related]
51. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
52. Self-assembled nanostructures of oleic acid and their capacity for encapsulation and controlled delivery of nutrients.
Abraham S; Narine SS
J Nanosci Nanotechnol; 2009 Nov; 9(11):6326-34. PubMed ID: 19908530
[TBL] [Abstract][Full Text] [Related]
53. The preparation of colloidally stable, water-soluble, biocompatible, semiconductor nanocrystals with a small hydrodynamic diameter.
Lees EE; Nguyen TL; Clayton AH; Muir BW; Mulvaney P
ACS Nano; 2009 May; 3(5):1121-8. PubMed ID: 19388661
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the binding properties of maghemite nanoparticle surface-coated with meso-2-3-dimercaptosuccinic acid to serum albumin.
Simoni AR; Garcia MP; Azevedo RB; Chaves SB; Lacava ZG; Lima EC; Morais PC; Tedesco AC
J Nanosci Nanotechnol; 2008 Nov; 8(11):5813-7. PubMed ID: 19198310
[TBL] [Abstract][Full Text] [Related]
55. Phosphorus doping of ultra-small silicon nanocrystals.
Perego M; Bonafos C; Fanciulli M
Nanotechnology; 2010 Jan; 21(2):025602. PubMed ID: 19955620
[TBL] [Abstract][Full Text] [Related]
56. Solid formulations by a nanocrystal approach: critical process parameters regarding scale-ability of nanocrystals for tableting applications.
Tuomela A; Laaksonen T; Laru J; Antikainen O; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
Int J Pharm; 2015 May; 485(1-2):77-86. PubMed ID: 25746735
[TBL] [Abstract][Full Text] [Related]
57. Novel thermosensitive nano-micelles from triblock copolymer for drug delivery.
Liu P; Wang B; Qiao W; Li J
J Biomed Nanotechnol; 2009 Jun; 5(3):310-3. PubMed ID: 20055013
[TBL] [Abstract][Full Text] [Related]
58. Mechanical and electronic-structure properties of compressed CdSe tetrapod nanocrystals.
Schrier J; Lee B; Wang LW
J Nanosci Nanotechnol; 2008 Apr; 8(4):1994-8. PubMed ID: 18572604
[TBL] [Abstract][Full Text] [Related]
59. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems.
Tavares Luiz M; Santos Rosa Viegas J; Palma Abriata J; Viegas F; Testa Moura de Carvalho Vicentini F; Lopes Badra Bentley MV; Chorilli M; Maldonado Marchetti J; Tapia-Blácido DR
Eur J Pharm Biopharm; 2021 Aug; 165():127-148. PubMed ID: 33992754
[TBL] [Abstract][Full Text] [Related]
60. Facile synthesis of Pt multipods nanocrystals.
Liang HP; Hu JS; Cao AM; Mu YY; Wan LJ
J Nanosci Nanotechnol; 2006 Jul; 6(7):2031-6. PubMed ID: 17025120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
